No recent analyst price targets found for XTLB.TA.
Latest News for XTLB.TA
XTL Announces Receipt of Staff Delist Determination from Nasdaq
RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE: XTLB. TA) (the "Company" or "XTL"), announced today that it has received a letter (the "Letter") from The Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq"), dated May 18, 2026, notifying the Company that since the Company has not yet filed its Annual Report on Form 20-F for the…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for XTLB.TA.
Senate Trading
No Senate trades found for XTLB.TA.
U.S. House Trading
No House trades found for XTLB.TA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.